Payal Dhar

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation”.

Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation

Communications Biology(2021)10.1038/s42003-021-02440-3

N/A

0.449DataRank · unranked

19 citations

Fahmin Basher, Zhe Ji, Lei Huang, Si Qin, Derek A. Wainwright +6 more

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy

Journal of Hematology & Oncology(2020)10.1186/s13045-020-00896-0

N/A

0DataRank · unranked

42 citations

Payal Dhar, Xin Wang, Derek A. Wainwright, Bin Zhang, Jeffrey A. Sosman +3 more

The clinical impact of soluble natural killer cell group 2-member D (NKG2D) receptor ligands on tumor tumorigenicity and anti-tumor immunity.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14557

N/A

0DataRank · unranked

1 citations

Pablo Sáenz-López, Payal Dhar, Sizhe Liu, Jennifer D. Wu, Anthony V. Serritella

The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes

Biomedicines(2024)10.3390/biomedicines12010196

N/A

0DataRank · unranked

3 citations

Pablo Saenz-Lopez Larrocha, Payal Dhar, Sizhe Liu, Milan M. Medd, Shengxian Jia +3 more